Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-14T10:17:29.924Z Has data issue: false hasContentIssue false
  • English
  • Français

COST-EFFECTIVENESS OF ADJUNCTIVE HYPERBARIC OXYGEN IN THE TREATMENT OF DIABETIC ULCERS

Published online by Cambridge University Press:  21 April 2004

Shien Guo ,
Michael A. Counte ,
Kathleen N. Gillespie  and
Homer Schmitz
Shien Guo
Affiliation:
Saint Louis University
Michael A. Counte
Affiliation:
Saint Louis University
Kathleen N. Gillespie
Affiliation:
Saint Louis University
Homer Schmitz
Affiliation:
Saint Louis University
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives: This study estimates the cost-effectiveness (CE) of the adjunctive use of hyperbaric oxygen (HBO2) therapy in the treatment of diabetic ulcers based on the payer's and societal perspectives.

Methods: The study population was a hypothetical cohort of 1,000 patients sixty years of age with severe diabetic foot ulcers. A decision tree model was constructed to estimate the CE of HBO2 therapy in the treatment of diabetic ulcers at years 1, 5, and 12. Scenario and one-way sensitivity analyses were also undertaken to identify parameters that may significantly influence the estimates.

Results: The CE model estimated that the incremental cost per additional quality-adjusted life year (QALY) gained at years 1, 5, and 12, was $27,310, $5,166, and $2,255, respectively.

Conclusions: The study results indicate that HBO2 therapy in the treatment of diabetic ulcers is cost-effective, particularly based on a long-term perspective. However, the results are limited by the clinical studies that provide the basis of the CE estimation.

Keywords

Hyperbaric oxygenDiabetic ulcersCost-effectivenessTechnology assessment
Type
RESEARCH NOTES
Information
International Journal of Technology Assessment in Health Care , Volume 19 , Issue 4 , December 2003 , pp. 731 - 737
Copyright
© 2004 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Arias E. 2000 United States life table, Center for Disease Control. Available at: http://www.cdc.gov/nchs/data/nvsr/nvsr51/nvsr51_03.pdf. Accessed February 11, 2003.
Baroni G, Porro T, Faglia E et al. 1987 Hyperbaric oxygen in diabetic gangrene treatment. Diabetes Care. 10: 81- 86.Google Scholar
Blid DE, Stevenson JM. 1992 Frequency of recording of diabetes on U.S. death certificates: Analysis of the 1986 National Mortality Followback Survey. J Clin Epidemiol. 45: 275- 281.Google Scholar
Braddeley RM, Fulford JC. 1965 A trial of conservative amputations for lesions of the feet in diabetes mellitus. Br J Surg. 52: 38- 43.Google Scholar
Cianci P. 1994 Adjunctive hyperbaric oxygen therapy in the treatment of the diabetic foot. J Am Podiatr Med Assoc. 84: 448- 455.Google Scholar
Cianci P, Hunt T. 2001 Adjunctive hyperbaric oxygen therapy in the treatment of the diabetic foot wound. In: Bowker J, Pfeifer M, eds. Levin and O'Neal's the diabetic foot. St. Louis: Mosby; 404- 421.
Ciaravino ME, Friedell ML, Kammerlocher TC. 1996 Is hyperbaric oxygen a useful adjunct in the management of problem lower extremity wounds? Ann Vasc Surg. 10: 558- 562.Google Scholar
Doctor N, Pandya S, Supe A. 1992 Hyperbaric oxygen therapy in diabetic foot. J Postgrad Med. 38: 112- 114.Google Scholar
Drummond MF, O'Brien B, Stoddart GL, Torrance GW. 1997 Methods for the economic evaluation of health care programs. New York: Oxford University Press
Eckman MH, Greenfield S, Mackey W et al. 1995 Foot infections in diabetic patients: Decision and cost-effectiveness analyses. JAMA. 273: 712- 720.Google Scholar
Faglia E, Favales F, Aldeghi A et al. 1996 Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. Diabetes Care. 19: 1338- 1343.Google Scholar
Garber AM, Phelps CE. 1997 Economic foundations of cost-effectiveness analysis. J Health Econ. 16: 1- 31.Google Scholar
Gold MR, Siegel J, Russell LB, Weinstein MC. 1996 Cost-effectiveness in health and medicine. New York: Oxford University Press
Gu K, Cowie CC, Harris MI. 1998 Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971–1993. Diabetes Care. 21: 1138- 1145.Google Scholar
Hammarlund C, Sundberg T. 1994 Hyperbaric oxygen reduced size of chronic leg ulcers: A randomized double-blind study. Plast Reconstr Surg. 93: 829- 833.Google Scholar
Hyperbaric Oxygen Therapy Association. The costs of hyperbaric oxygen therapy prepared by The Lewin Group. Available at: http://www.uhms.org/legislation/lewin.htm. Accessed June 20, 2002.
Lee SS, Chen CY, Chan YS et al. 1997 Hyperbaric oxygen in the treatment of diabetic foot. Chang Geng Med J. 20: 17- 22.Google Scholar
Ollendorf D, Kotsanos J, Wishner W et al. 1998 Potential economic benefits of lower-extremity amputation prevention strategies in diabetes. Diabetes Care. 21: 1240- 1245.Google Scholar
Oriani G, Meazza D, Favales F et al. 1990 Hyperbaric oxygen therapy in diabetic gangrene. J Hyperb Med. 5: 171- 174.Google Scholar
Oriani G, Michael M, Meazza D et al. 1992 Diabetic foot and hyperbaric oxygen therapy: A ten-year experience. J Hyperb Med. 7: 213- 221.Google Scholar
Plafki C, Peters P, Almeling M et al. 2000 Complications and side effects of hyperbaric oxygen therapy. Aviat Space Environ Med. 71: 119- 124.Google Scholar
Ragnarson-Tennvall G, Apelqvist J. 2000 Health-related quality of life in patients with diabetes mellitus and foot ulcers. J Diabetes Complications. 14: 235- 241.Google Scholar
Ramsey SD, Newton K, Blough D et al. 1999 Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 22: 382- 387.Google Scholar
Reiber GE. 2001 Epidemiology of foot ulcers and amputation in the diabetic foot. In: Bowker J, Pfeifer M, eds. Levin and O'Neal's the diabetic foot. St. Louis: Mosby; 13- 32.
Reiber GE, Lipsky BA, Gibbons GW. 1998 The burden of diabetic foot ulcers. Am J Surg. 176: 5s- 10s.Google Scholar
Wattel F, Mathieu D, Coget JM, Billard V. 1990 Hyperbaric oxygen therapy in chronic vascular wound management. Angiology. 41: 59- 65.Google Scholar
Willians RL, Armstrong DG. 1998 Wound healing. Clin Podiatr Med Surg. 15: 117- 128.Google Scholar
Wunderlich RP, Peters EJG, Lavery LA. 2000 Systemic hyperbaric oxygen therapy: Lower-extremity wound healing and the diabetic foot. Diabetes Care. 23: 1551- 1555.Google Scholar
Zamboni WA, Wong HP, Stephenson LL, Pfeifer MA. 1997 Evaluation of hyperbaric oxygen for diabetic wounds: A prospective study. Undersea Hyperb Med. 24: 175- 179.Google Scholar